Heart Failure POC and LOC Devices Market Trends

Heart Failure POC and LOC Devices Market Trends

The increasing prevalence of heart failure and cardiovascular diseases is a significant driver for market. These diseases are major global health concerns affecting millions of individuals worldwide.
 

• According to the National Library of Medicine, in 2023, heart failure affects more than 64 million people worldwide. As per the same report, in 2021, heart failure was mentioned on 379,800 death certificates (13.4%).
   
• Further, as per the American Heart Association (AHA) report, in 2023, heart disease affects about 2.5% of the U.S. population. Similarly, according to the Journal of Cardiac Failure, in 2023, the overall prevalence of heart failure among U.S. adults has ranged from 1.9% to 2.6% for the overall population.
   
• Early diagnosis and intervention are critical for managing heart failure and CVD effectively and preventing disease progression. POC devices enable rapid assessment of cardiac function, hemodynamic parameters, and oxygenation status at the point of care allow healthcare providers to diagnose heart failure promptly, initiate appropriate treatment, and optimize patient outcomes.
   
• There is a growing emphasis on value-based care and healthcare delivery models that prioritize preventive strategies, early detection, and proactive management of chronic conditions such as heart failure and CVD. POC and LOC devices support these initiatives by enabling timely interventions, reducing hospital readmissions, and improving patient outcomes, thereby lowering healthcare costs, and enhancing the quality of care.